domingo, 18 de abril de 2021

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

No hay comentarios:

Publicar un comentario